Similar articles

• A rationale for setting target plasma lipid levels to reverse atherosclerosis.

  Parker TS, Saal SD, Gordon BR, Tyberg TI, Levine DM, Rubin AL. Parker TS, et al. Beitr Infusionsther. 1988;23:132-7. Beitr Infusionsther. 1988. PMID: 2484767 Review. No abstract available.
• Regression of atherosclerosis.

  Garber AJ. Garber AJ. Curr Ther Endocrinol Metab. 1994;5:484-91. Curr Ther Endocrinol Metab. 1994. PMID: 7704778 No abstract available.
• [The relationships of HDL- and LDL-cholesterol to cerebral infarction and to atherosclerosis--clinical and pathological study (author's transl)].

  Yamanouchi H, Tohgi H, Okabe H, Shimada H. Yamanouchi H, et al. Nihon Ronen Igakkai Zasshi. 1981 May;18(3):148-52. Nihon Ronen Igakkai Zasshi. 1981. PMID: 7289181 Japanese. No abstract available.
• Role of low-density lipoprotein apheresis.

  Ziajka P. Ziajka P. Am J Cardiol. 2005 Aug 22;96(4A):67E-69E. doi: 10.1016/j.amjcard.2005.06.012. Am J Cardiol. 2005. PMID: 16098847 Review.
• Diet and drug treatment of hyperlipidemia and atherosclerosis.

  Kuo PT. Kuo PT. Ann Clin Lab Sci (1971). 1972 Jul-Aug;2(4):322-4. Ann Clin Lab Sci (1971). 1972. PMID: 4342101 No abstract available.